Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways

Paul Dowell1, Tamara C Otto, Saleh Adi

  • 1Biological Chemistry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. dowellp@jhmi.edu

Insights

The forkhead factor Foxo1 antagonizes PPARgamma activity, impacting insulin signaling. This interaction, conserved across species, suggests a convergence of nuclear hormone receptor and forkhead factor pathways in biological processes.

Area of Science:

  • Molecular Biology
  • Genetics
  • Endocrinology

Background:

  • The forkhead factor Foxo1 (FKHR) interacts with peroxisome proliferator-activated receptor gamma (PPARgamma).
  • Foxo1 and PPARgamma exhibit reciprocal antagonism, suggesting functional interaction.
  • Both factors are linked to mammalian insulin signaling pathways.

Purpose of the Study:

  • To investigate the functional interaction between Foxo1 and PPARgamma.
  • To explore the role of this interaction in insulin signaling.
  • To examine the evolutionary conservation of nuclear hormone receptor and forkhead factor pathways.

Main Methods:

  • Yeast two-hybrid screening to identify interacting proteins.
  • Assays to assess DNA binding activity of transcription factor complexes.
  • Comparative analysis of homologous interactions in Caenorhabditis elegans.

Main Results:

  • Foxo1 was identified as a PPARgamma-interacting protein.
  • Foxo1 antagonizes PPARgamma activity by disrupting its DNA binding.
  • A similar interaction between DAF-12 (nuclear hormone receptor) and DAF-16 (forkhead factor) was observed in C. elegans.
  • Both interactions are implicated in insulin signaling pathways.

Conclusions:

  • Foxo1 and PPARgamma signaling converge, potentially influencing insulin action.
  • This convergence may explain the insulinomimetic properties of PPARgamma ligands.
  • A broader convergence between nuclear hormone receptor and forkhead factor pathways is likely conserved and important for various biological processes.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...